Li Jianwei
SEC CIK 1858469 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ESLA | Estrella Immunopharma, Inc. | Co-CEO, Dir, 10% | 1.25M | — | — | 1 | 2022-03-04 | 2022-03-04 |
Most active insiders at ESLA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Liu Cheng | CEO, Dir | — | — |
| 2 | Xu Jiandong | CFO | — | — |
Li Jianwei made no open-market trades at ESLA in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | 2022-03-17 | 2022-03-04 | ESLA | Estrella Immunopharma, Inc. | Li Jianwei | Co-CEO, Dir, 10% | P - Purchase | $314,700.00 | +142.0K | 1.25M | +13% | — |
Purchase Sale Sale after option exercise All abbreviations